ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Indianapolis, IN, USA:

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T)

The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Overall Survival (OS) in Acute...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Cancer
Drug: Venetoclax
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Indianapolis, Indiana, United States and 164 other locations

or young adults with a certain kind of blood cancer (FLT3-ITD AML) might be able to join this study if it has come back after remission or i...

Enrolling
Acute Myeloid Leukemia
Drug: Quizartinib
Drug: Cytarabine

Phase 1, Phase 2

Daiichi Sankyo
Daiichi Sankyo

Indianapolis, Indiana, United States and 36 other locations

Eligible untreated patients with FLT3 acute myeloid leukemia (AML) between the ages of 18 and 70 will be randomiz...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Gilteritinib
Drug: Daunorubicin

Phase 2

PrECOG

Indianapolis, Indiana, United States and 43 other locations

in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Decitabine and Cedazuridine (ASTX727)
Drug: Venetoclax

Phase 1, Phase 2

Taiho Pharma
Taiho Pharma

Indianapolis, Indiana, United States and 33 other locations

menin-MLL(KMT2A) inhibitor, in patients with relapsed or refractory acute myeloid leukemia (AML) as part of Phase....

Enrolling
Acute Leukemia of Ambiguous Lineage
Mixed Phenotype Acute Leukemia
Drug: Ziftomenib

Phase 1, Phase 2

Kura Oncology

Indianapolis, Indiana, United States and 51 other locations

with Gemtuzumab Ozogamicin(GO) in subjects with relapsed/refractory acute myeloid leukemia. Using a standard 3+3 design, s...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Gemtuzumab Ozogamicin

Phase 1

John Quigley

Indianapolis, Indiana, United States and 3 other locations

with fludarabine and cytarabine in treating patients with acute myeloid leukemia (AML), myelodysplastic syndrome ...

Enrolling
Refractory Juvenile Myelomonocytic Leukemia
Refractory Childhood Acute Myeloid Leukemia
Drug: Cytarabine
Drug: Fludarabine

Phase 1

Children's Oncology Group

Indianapolis, Indiana, United States and 7 other locations

myeloid leukemia (AML) in transfusion-dependent participants with low or immediate-1 risk MDS that is relapsed/refractory...

Active, not recruiting
Myelodysplastic Syndromes
Drug: Placebo
Drug: Imetelstat

Phase 2, Phase 3

Geron

Indianapolis, Indiana, United States and 126 other locations

Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior in...

Enrolling
Leukemia, Myeloid, Acute
Drug: Cytarabine
Drug: Etoposide

Phase 3

Delta-Fly Pharma

Indianapolis, Indiana, United States and 38 other locations

chemotherapy and bone marrow transplantation in newly diagnosed AML subjects with FLT3 mutation. About 510 subjects will be randomized in a ...

Enrolling
Newly Diagnosed FLT3 Mutated AML
Drug: Cytarabine
Drug: Duanorubicin

Phase 3

Arog Pharmaceuticals

Indianapolis, Indiana, United States and 30 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems